Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKinsey
Covington
Merck
Cipla
Chinese Patent Office
QuintilesIMS
Baxter
Queensland Health

Generated: July 15, 2018

DrugPatentWatch Database Preview

Hydrocortisone; polymyxin b sulfate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for hydrocortisone; polymyxin b sulfate and what is the scope of hydrocortisone; polymyxin b sulfate patent protection?

Hydrocortisone; polymyxin b sulfate
is the generic ingredient in two branded drugs marketed by Schering and Forest Labs, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-four drug master file entries for hydrocortisone; polymyxin b sulfate.
Summary for hydrocortisone; polymyxin b sulfate
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 64
DailyMed Link:hydrocortisone; polymyxin b sulfate at DailyMed

US Patents and Regulatory Information for hydrocortisone; polymyxin b sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs PYOCIDIN hydrocortisone; polymyxin b sulfate SOLUTION/DROPS;OTIC 061606-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering OTOBIOTIC hydrocortisone; polymyxin b sulfate SOLUTION/DROPS;OTIC 062302-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cipla
Dow
Harvard Business School
Colorcon
Baxter
Argus Health
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.